Arrowhead Pharmaceuticals (ARWR) News Today $35.41 -0.65 (-1.80%) Closing price 10/10/2025 04:00 PM EasternExtended Trading$35.05 -0.36 (-1.01%) As of 10/10/2025 07:47 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock ARWR Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent October 2025 September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 Time Period Pinion Investment Advisors LLC Has $1.19 Million Stock Position in Arrowhead Pharmaceuticals, Inc. $ARWROctober 11 at 6:08 AM | marketbeat.comArrowhead Pharmaceuticals' (ARWR) "Buy" Rating Reiterated at HC WainwrightOctober 11 at 2:07 AM | americanbankingnews.comH.C. Wainwright Reaffirms Their Buy Rating on Arrowhead Pharmaceuticals (ARWR)October 10 at 4:15 AM | theglobeandmail.comWealth Enhancement Advisory Services LLC Invests $262,000 in Arrowhead Pharmaceuticals, Inc. $ARWROctober 10 at 3:20 AM | marketbeat.comWeiss Ratings Reaffirms Sell (D-) Rating for Arrowhead Pharmaceuticals (NASDAQ:ARWR)October 9 at 5:44 PM | marketbeat.comHC Wainwright & Co. Reiterates Arrowhead Pharmaceuticals (ARWR) Buy RecommendationOctober 8 at 4:56 PM | msn.comArrowhead Pharmaceuticals (NASDAQ:ARWR) Given Buy Rating at HC WainwrightOctober 8 at 8:26 AM | marketbeat.comArrowhead Pharmaceuticals Files CTA for Investigational ARO-DIMER-PA – the First Dual Functional RNAi Therapeutic for the Treatment of Mixed HyperlipidemiaOctober 7, 2025 | businesswire.comArrowhead Pharmaceuticals (NASDAQ:ARWR) Reaches New 12-Month High - Still a Buy?October 6, 2025 | marketbeat.comArrowhead Pharmaceuticals (ARWR) Receives a Buy from Bank of America SecuritiesOctober 6, 2025 | theglobeandmail.comInsider Selling: Arrowhead Pharmaceuticals (NASDAQ:ARWR) Insider Sells 20,000 Shares of StockOctober 3, 2025 | marketbeat.comPlatinum Investment Management Ltd. Has $1.75 Million Holdings in Arrowhead Pharmaceuticals, Inc. $ARWROctober 2, 2025 | marketbeat.comArrowhead Pharmaceuticals, Inc.'s (NASDAQ:ARWR) Intrinsic Value Is Potentially 72% Above Its Share PriceOctober 1, 2025 | finance.yahoo.comArrowhead Pharmaceuticals (NASDAQ:ARWR) Hits New 1-Year High - What's Next?September 30, 2025 | marketbeat.com13,500 Shares in Arrowhead Pharmaceuticals, Inc. $ARWR Acquired by Moody Lynn & Lieberson LLCSeptember 30, 2025 | marketbeat.comArrowhead Pharmaceuticals, Inc. $ARWR Stock Position Decreased by Voya Investment Management LLCSeptember 28, 2025 | marketbeat.comArrowhead Pharmaceuticals (NASDAQ:ARWR) Reaches New 52-Week High - What's Next?September 24, 2025 | marketbeat.comArrowhead Pharmaceuticals (NASDAQ:ARWR) Reaches New 1-Year High - Here's What HappenedSeptember 19, 2025 | marketbeat.comHC Wainwright Has Bearish Estimate for ARWR FY2025 EarningsSeptember 18, 2025 | marketbeat.comArrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) Given Average Rating of "Buy" by AnalystsSeptember 18, 2025 | marketbeat.comArrowhead Pharmaceuticals (NASDAQ:ARWR) Insider James Hamilton Sells 15,000 SharesSeptember 17, 2025 | marketbeat.comArrowhead Pharmaceuticals (NASDAQ:ARWR) Insider Sells $450,000.00 in StockSeptember 17, 2025 | insidertrades.comArrowhead Pharmaceuticals, Inc. $ARWR Shares Sold by Rhumbline AdvisersSeptember 16, 2025 | marketbeat.comUBS AM A Distinct Business Unit of UBS Asset Management Americas LLC Purchases 2,774,933 Shares of Arrowhead Pharmaceuticals, Inc. $ARWRSeptember 16, 2025 | marketbeat.comWoodline Partners LP Has $7.16 Million Stake in Arrowhead Pharmaceuticals, Inc. $ARWRSeptember 15, 2025 | marketbeat.comArrowhead Pharmaceuticals (NASDAQ:ARWR) Trading 4.3% Higher - Should You Buy?September 14, 2025 | marketbeat.comCantor Fitzgerald Brokers Cut Earnings Estimates for ARWRSeptember 14, 2025 | marketbeat.comArrowhead Pharmaceuticals (NASDAQ:ARWR) Sets New 1-Year High - What's Next?September 13, 2025 | marketbeat.comBank of America Securities Sticks to Its Buy Rating for Arrowhead Pharmaceuticals (ARWR)September 13, 2025 | theglobeandmail.comArrowhead Pharmaceuticals Faces Patent Lawsuit from IonisSeptember 13, 2025 | msn.comIonis, Arrowhead file dueling patent lawsuits over genetic-disorder drugSeptember 11, 2025 | reuters.comArrowhead Pharmaceuticals Files Complaint for Declaratory Judgment Against Ionis PharmaceuticalsSeptember 11, 2025 | businesswire.comArrowhead Pharmaceuticals, Inc. (ARWR) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference TranscriptSeptember 10, 2025 | seekingalpha.comH.C. Wainwright Reiterated a Buy on Arrowhead Pharmaceuticals (ARWR)September 10, 2025 | insidermonkey.comArrowhead Pharmaceuticals, Inc. (ARWR) Presents At H.C. Wainwright 27th Annual Global Investment Conference TranscriptSeptember 9, 2025 | seekingalpha.comArrowhead Pharmaceuticals, Inc. $ARWR Shares Sold by Corebridge Financial Inc.September 9, 2025 | marketbeat.comArrowhead Pharmaceuticals, Inc. $ARWR Shares Sold by MetLife Investment Management LLCSeptember 8, 2025 | marketbeat.comHsbc Holdings PLC Acquires Shares of 13,850 Arrowhead Pharmaceuticals, Inc. $ARWRSeptember 8, 2025 | marketbeat.comArrowhead Pharmaceuticals, Inc. (ARWR) Presents At Cantor Global Healthcare Conference 2025 TranscriptSeptember 7, 2025 | seekingalpha.comEquities Analysts Set Expectations for ARWR FY2026 EarningsSeptember 7, 2025 | marketbeat.comFY2025 Earnings Estimate for ARWR Issued By Zacks Small CapSeptember 7, 2025 | marketbeat.comRussell Investments Group Ltd. Cuts Stake in Arrowhead Pharmaceuticals, Inc. $ARWRSeptember 7, 2025 | marketbeat.comArrowhead Pharmaceuticals (NASDAQ:ARWR) Hits New 52-Week High - Still a Buy?September 5, 2025 | marketbeat.comArrowhead Pharmaceuticals (NASDAQ:ARWR) Trading Up 11% - Here's WhySeptember 4, 2025 | marketbeat.comHC Wainwright Reaffirms Buy Rating for Arrowhead Pharmaceuticals (NASDAQ:ARWR)September 4, 2025 | marketbeat.comADAR1 Capital Management LLC Boosts Stock Holdings in Arrowhead Pharmaceuticals, Inc. $ARWRSeptember 4, 2025 | marketbeat.comNorthern Trust Corp Sells 273,606 Shares of Arrowhead Pharmaceuticals, Inc. $ARWRSeptember 4, 2025 | marketbeat.comArrowhead Pharmaceuticals, Inc. (ARWR) Presents At Citi's 2025 Biopharma Back To School Conference (Transcript)September 3, 2025 | seekingalpha.comArrowhead: Upcoming Plozasiran PDUFA Review Date And Subsequent Expansion In PlaceSeptember 3, 2025 | seekingalpha.comArrowhead Pharma Jumps After Inking A Deal Worth Up To $2.2 BillionSeptember 3, 2025 | msn.com Get Arrowhead Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for ARWR and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. ARWR Media Mentions By Week ARWR Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ARWR News Sentiment▼0.480.77▲Average Medical News Sentiment ARWR News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ARWR Articles This Week▼128▲ARWR Articles Average Week Get the Latest News and Ratings for ARWR and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Arrowhead Pharmaceuticals and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies Summit Therapeutics News Ascendis Pharma A/S News Viatris News Dr. Reddy's Laboratories News Roivant Sciences News Moderna News Qiagen News BridgeBio Pharma News Elanco Animal Health News Verona Pharma PLC American Depositary Share News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ARWR) was last updated on 10/11/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | Sponsored2013 miner reveals his trading systemWhile everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredForget AI, This Will Be the Next Big Tech BreakthroughAfter picking Nvidia in 2016, before it jumped 27,000%... Jeff Brown is back with what he believes will be ...Brownstone Research | SponsoredFront-Run Buffett's Shocking Gold MoveA Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredIf You Keep Cash In A U.S. Bank Account… Read This NOWThe Treasury Department just issued a stunning warning: U.S. banks could lose up to $6.6 trillion of custom...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Arrowhead Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Arrowhead Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
